β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease

ConclusionsIncreased β-amyloid or low MOTS-c are additive predictors to high on-clopidogrel platelet reactivity for adverse outcome in diabetics with CAD during 2-years follow-up. Clinical Trial Registration-URL:https://www.clinicaltrials.gov. Unique identifier: NCT04027712.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research